Australia markets close in 41 minutes

Proteomics International Laboratories Limited (PIQ.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.0800-0.0050 (-0.46%)
As of 03:00PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 142.02M
Enterprise value 137.09M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)223.67
Price/book (mrq)26.54
Enterprise value/revenue 235.86
Enterprise value/EBITDA -16.93

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 330.72%
S&P500 52-week change 325.01%
52-week high 31.4000
52-week low 30.7000
50-day moving average 31.1145
200-day moving average 30.9437

Share statistics

Avg vol (3-month) 3307.98k
Avg vol (10-day) 3216.09k
Shares outstanding 5130.89M
Implied shares outstanding 6133.91M
Float 8105M
% held by insiders 130.96%
% held by institutions 16.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -194.61%
Operating margin (ttm)-636.67%

Management effectiveness

Return on assets (ttm)-49.23%
Return on equity (ttm)-97.26%

Income statement

Revenue (ttm)3.03M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-19.40%
Gross profit (ttm)N/A
EBITDA -5.65M
Net income avi to common (ttm)-5.9M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.97M
Total cash per share (mrq)0.04
Total debt (mrq)46.39k
Total debt/equity (mrq)0.89%
Current ratio (mrq)4.34
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-5.19M
Levered free cash flow (ttm)-3.32M